Musculoskeletal manifestations in cystic fibrosis

Joint Bone Spine

Volumn 70, Issue 5, 2003, Pages 327-335

  Botton, Estelle ^a   Saraux, Alain ^a   Laselve, Hermine ^b   Jousse, Sandrine ^a   Le Goff, Paul ^a  

^a SERVICE DE RHUMATOLOGIE   (France)

^b Centre Hélio marin   (France)

Author keywords

Arthralgia; Arthritis; Cystic fibrosis; Demineralization; Immunological manifestations

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; AZUROCIDIN; BACTERICIDAL PERMEABILITY INCREASING PROTEIN; CALCIUM ION; HEAT SHOCK PROTEIN; KERATIN ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHATE; RHEUMATOID FACTOR; VITAMIN D;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTHRALGIA; ARTHRITIS; BONE DEMINERALIZATION; BONE DENSITY; BONE MASS; CHILD; CYSTIC FIBROSIS; FEMALE; HUMAN; HYPERTROPHIC OSTEOARTHROPATHY; IMMUNOLOGY; IMMUNOPATHOGENESIS; KNEE PAIN; MALE; MUSCULOSKELETAL DISEASE; OSTEOLYSIS; PATHOPHYSIOLOGY; PRESCHOOL CHILD; RASH; REVIEW;

EID: 0141920624     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1297-319X(03)00063-0     Document Type: Short Survey

References (131)

1. Parasa RB, Maffulli N. Musculoskeletal involvement in cystic fibrosis. Bull Hosp Jt Dis 1999;58:37-44.
2. Rush PJ, Gladman DD, Shore A, Anhom KA. Absence of an association between HLA typing in cystic fibrosis arthritis and hypertrophic osteoarthropathy. Ann Rheum Dis 1991;50;763-4.
3. Massie RJH, Towns SJ, Bernard E, Chaitow J, Howman-Giles R, Van Asperen PP. The muscu-loskeletal complications of cystic fibrosis. J Paediatr Child Health 1998;34:467-70.
4. Verlingue C, Travert G, Le Roux MG, Laroche D, Audrezet MP, Mercier B, et al. Les mutations du gène de la mucoviscidose dans l'ouest de la France: application clinique. Ann Biol Clin 1994;52: 757-64.
5. Boat TF, Welsh MJ, Beaudet AL. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic basis of inherited disease. New York: Mc Graw Hill; 1989. p. 2649-80.
6. Crossley JR, Elliott RB, Smith PA. Dried-blood spot screening for cystic fibrosis in the new-bom. Lancet 1979;i:472-4.
7. Scotet V, de Braekeleer M, Roussey M, Rault G, Parent P, Dagome M, et al. Neo-natal screening for cystic fibrosis in Brittany, France: assessment of 10 years experience and impact on prenatal diagnosis. Lancet 2000;356(9232):789-94.
8. Tsui LC, Buchwald M, Barker D, Braman JC, Knowlton R, Schumm JW, et al. Cystic fibrosis locus defined by a genetically polymorphic DNA marker. Science 1985;230:1054-7.
9. Kerem BS, Rommens JM, Buchana JA, Markiewicz D, Cox TK, Chakravarti A, et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989;245:1073-80.
10. Riordan JR, Rommens JM, Kerem BS, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterisation of complementary DNA. Science 1989;245:1066-73.
11. Rommens JM, Lannuzzi MC, Kerem BS, Drumm ML, Melmer G, Dean M, et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989;245:1059-64.
12. The cystic fibrosis genetic analysis consortium. Worldwide survey of the delta F508 mutation report. Am J Hum Genet 1990;47:354-9.
13. European working group on CF genetics (EWGCFG). Gradient of distribution in Europe of the major CF mutation and of its associated haplotype. Hum Genet 1990;85:436-45.
14. Di Sant'Agnese PA, Darling RC, Perera GA, Shea E. Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas. Clinical significance and relationship to the dis-ease. Pediatrics 1953; 12:549.
15. Kirk JM, Keston M, McIntosh I, Al Essa S. Variation of sweat sodium and chloride with age in cystic fibrosis and normal populations: further investigations in equivocal cases. Ann Clin Biochem 1992;29: 145-52.
16. Mischler EH, Chesney PJ, Chesney RW, Mazess RB. Demineralization in cystic fibrosis. Arch Pediatr Adolesc Med (Am J Dis Child) 1979;133:632-5.
17. De Schepper J, Smitz J, Dab I, Piepsz A, Jonckheer M, Bergmann P. Low serum bone gamma-carboxyglutamic acid protein concentrations in patients with cystic fibrosis: correlation with hormonal parameters and bone mineral density. Hormone Res 1993;39:197-201.
18. Gibbens DT, Gilsanz V, Boechat MI, Dufer D, Carlson ME, Wang CI. Osteoporosis in cystic fibrosis. J Pediatr 1988;113:295-300.
19. Henderson RC, Madsen CD. Bone density in children and adolescents with cystic fibrosis. J Pediatr 1996;128:28-34.
20. Sood M, Hambleton G, Super M, Adams J, Mughal Z. Bone density in children with cystic fibrosis. 21st European cystic fibrosis conference Davos, Switzerland [abstract 62]. June 1997.
21. Stillwell PC, Mallory Jr GB. Pediatric lung transplantation. Clin Chest Med 1997;18:405-14.
22. Parsons HG, Beaudry P, Dumas A, Pencharz PB. Energy needs and growth in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 1983;2:44-9.
23. Stamp TC, Geddes DM. Osteoporosis and cystic fibrosis. Thorax 1993;48:585-6.
24. Bachrach LK, Loutit CW, Moss RB. Osteopenia in adults with cystic fibrosis. Am J Med 1994;96:27-34.
25. Donovan Jr DS, Papadopoulos A, Staron RB, Addesso V, Schulman L, Mc Gregor C, et al. Bone mass and vitamin D deficiency in adults with advanced cystic fibrosis disease. Am J Respir Crit Care Med 1998; 157:1892-9.
26. Grey AB, Ames RW, Matthews RD, Reid IR. Bone mineral density and body composition in adults patients with cystic fibrosis. Thorax 1993;48:589-93.
27. Ruiz JC, Mandel C, Garabedian M. Influence of spontaneous calcium intake and physical exercise on the vertebral and femoral bone mineral density of children and adolescents. J Bone Min Res 1995; 10:675-82.
28. Bhudhikanok GS, Wang MC, Marcus R, Harkins A, Moss RB, Bachrach LK. Bone acquisition and loss in children and adults with cystic fibrosis: a longitudinal study. J Pediatr 1998;133:18-27.
29. Kröger H, Kotaniemi A, Vainio P, Alhava E. Bone densitometry of the spine and femur in children by dual-energy X-ray absorptiometry. Bone Miner 1992;17:75-85.
30. Slemenda CW, Miller JZ, Hui SL, Reister TK, Johnston CC. Role of physical activity in the development of skeletal mass in children. J Bone Miner Res 1991;6:1227-33.
31. Bhudhikanok GS, Lim J, Marcus R, Harkins A, Moss RB, Bachrach LK. Correlates of osteopenia in patients with cystic fibrosis. Pediatrics 1996;97:103-11.
32. Haworth CS, Dodd ME, Verma A, Economou G. The prevalence of osteoporosis in adults with cystic fibrosis. Thorax 1997;52(Suppl 6):A44.
33. Heaney RP. Nutrition and risk for osteoporosis. In: Marcus R, Feldman D, Kel-sey J, editors. Osteoporosis. San Diego: Academic Press; 1996. p. 483-505.
34. Johnston CC, Miller JZ, Slemenda CW, Reister TK, Hui S, Christian JC. Calcium supplementation and increases in bone mineral density in children. N Engl J Med 1992;327:82-7.
35. Lambert JP. Osteoporosis: a new challenge in cystic fibrosis. Pharmacotherapy 2000;20:34-51.
36. Soejima K, Landing BH. Osteoporosis in juvenile-onset diabetes mellitus: morphometric and comparative studies. Pediatr Pathol 1986; 6:289-99.
37. Henderson RC, Madsen CD. Bone mineral content and body composition in chil-dren and young adults with cystic fibrosis. Pediatr Pulmonol 1999;27:80-4.
38. Stead RJ, Houlder S, Agnew J. Vitamin D and parathyroid hormone and bone miner-alisation in adults with cystic fibrosis. Thorax 1988; 43:190-4.
39. Salamoni F, Roulet M, Gudinchet F, Pilet M, Thiebaud D, Burckardt P. Bone mineral content in cystic fibrosis patients: correlation with fat-free mass. Arch Dis Child 1996;74:314-8.
40. Dingman S, Lester G, Aris R, et al. Impaired absorption of dietary calcium by young adults with cystic fibrosis ASBMR Annual Meeting [abstract T509]. 1997.
41. Ott SM, Aitken ML. Osteoporosis in patients with cystic fibrosis. Clin Chest Med 1998;19:555-67.
42. Hanly JG, Mc Keene MJ, Quigley C, Freaney R, Muldowney FP, Fitz-gerald MX. Hypovitaminosis D and response to supplementation in older patients with cystic fibrosis. Q J Med 1985;219:377-85.
43. Haworth CS, Selby PL, Webb AK. Low bone mineral density in adult patients with cystic fibrosis. Thorax 1999;54:961-7.
44. Reiter EO, Brugman SM, Pike JW. Vitamin D metabolites in adolescents and young adults with cystic fibrosis: effects of sun and season. J Pediatr 1985;106:21-6.
45. Aris RM, Renner JB, Winders AD, Buell HE, Riggs DB, Lester GE, et al. Increased rate of fractures and severe kyphosis: sequelae of living into adults with cystic fibrosis. An Intern Med 1998;128:186-93.
46. Henderson RC, Specter BB. Kyphosis and fractures in children and young adults with cystic fibrosis. J Pediatr 1994;125:208-12.
47. Conway SP, Morton AM, Oldroy B, Truscott JG, White H, Smith AH, et al. Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors. Thorax 2000;55:798-804.
48. Gaffney K, Gibbons D, Keogh B, Fitzgerald MX. Amyloidosis complicating cystic fibrosis. Thorax 1993;48:949-50.
49. Merkel PA, Herliyn K, Lapey A, Anderson EJ, Schoenfeld D, Finkelstein JS. Osteoporosis in adults with cystic fibrosis. Pediatr Pulmonol 1997(Suppl 14):311.
50. Shane E, Silverberg SJ, Donovan D, Papadopoulos A, Staron RB, Addesso V, et al. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Am J Med 1996;101:262-9.
51. Hahn TJ, Squires AE, Halstead LR, Strominger DB. Reduced serum 25-hydroxyvitamin D concentration and disordered mineral metabolism in patients with cystic fibrosis. J Pediatr 1979;94:38-42.
52. Burdge GC, Doull I, Rolles CJ. Analysis of plasma vitamin D concentration in chil-dren with CF. Pediatr Pulmonol 1997(Suppl 14):312.
53. Solomons NW, Wagonfeld JB, Rieger C Some biochemical indices of nutrition in treated cystic fibrosis patients. Am J Clin Nutr 1981;34: 462-74.
54. Aris RM, Neuringer IP, Weiner MA, Egan TM, Ontjes D. Severe osteoporosis before and after lung transplantation. Chest 1996;109: 1176-83.
55. Haworth CS, Freemont AJ, Webb AK, Dodd ME, Selby PL, Mawer EB, et al. Hip fracture and bone histomorphometry in a young adult with cystic fibrosis. Eur Respir J 1999;14:478-9.
56. Hubbard VS, Farrell PM, di Sant'Agnese PA. 25 hydroxycholecalciferol levels in patients with cystic fibrosis. J Pediatr 1979;94:84-6.
57. Rochat T, Slosman D, Pichard C, Belli D. Body composition analysis by dual-energy X-ray absorptiometry in adults with cystic fibrosis. Chest 1994;106:800-5.
58. Shaw N, Bedford C, Heaf D, Carty H. Osteopenia in adults with cystic fibrosis. Am J Med 1995;99:690-2.
59. Weisman Y, Reiter E, Stem RC, Root A. Serum concentrations of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D in patients with cystic fibrosis. J Pediatr 1979;95:416-8.
60. Haworth CS, Webb AK, Egan JJ, Selby PL, Hasleton PS, Bishop PW, et al. Bone histomorphometry in adults patients with cystic fibrosis. Chest 2000;118:434-9.
61. Oppenheimer EH, Esterly JR. Pathology of cystic fibrosis: review of the litera-ture and comparison with 146 autopsied cases. Perspect Pediatr Pathol 1975;2:241-78.
62. Merkel PA, Rheumatic disease and cystic fibrosis. Arthritis Rheum 1999;42:1563-71.
63. Aris RM, Lester G, Renner JB, Winders A, Blackwood AD, Lark RK, et al. Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation. Am J Respir Crit Care Med 2000;162:941-6.
64. Baroncelli GI, De Luca F, Magazzu G, Arrigo T, Sferlazzas C, Catena C, et al. Bone demineralization in cystic fibrosis: evidence of imbalance between bone formation and degradation. Pediatr Res 1997;41:397-403.
65. Huang NN, Schildow DV, Szatrowski TH. Clinical features, survival rate, and prognostic factors in young adults with cystic fibrosis. Am J Med 1987;82:871-9.
66. Nixon LS, Yung B, Bell SC, Stuart Elbom J, Shale DJ. Circulating immunoreactive interleukin-6 in cystic fibrosis. Am J Respir Crit Care Med 1998;157:1764-9.
67. Teramoto S. Mechanism of osteoporosis in patients with cystic fibrosis. Thorax 2000;55:439.
68. Teramoto S, Matsuse T, Ouchi Y. Increased production of TNF-alpha may play a role in osteoporosis in cystic fibrosis patients. Chest 1997;112:574.
69. Rush PJ, Shore A, Coblentz C, Wilmot D, Corey M, Levinson H. The musculoskeletal manifestations of cystic fibrosis. Semin Arthritis Rheum 1986;15:213-25.
70. Matthieu JP, Stack BH, Dick WC, Buchanan WW. Pulmonary infection and rheumatoid arthritis. Br J Dis Chest 1978;72:57-61.
71. Newman AJ, Ansell Ansell BM. Episodic arthritis in children with cystic fibrosis. J Pediatr 1979;94:594-6.
72. Al-Shamma MR, McSharry C, McLeod K, McCruden EA, Stack BH. Role of heat shock proteins in the pathogenesis of cystic fibrosis arthritis. Thorax 1997;52:1056-9.
73. Bourke S, Rooney M, Fitzgerald M, Brenishan B. Episodic arthropathy in adult cystic fibrosis. Q J Med 1987;64:651-9.
74. Dixey J, Redington AN, Butler RC, Smith MJ, Batchelor JR, Woodrow DF, et al. The arthropathy of cystic fibrosis. Ann Rheum Dis 1988;47:218-23.
75. Jones SM, McKay KM, McHUgh NJ. Bilateral hip replacements in a man with cystic fibrosis and episodic arthritis. Br J Rheumatol 1997; 36:298-9.
76. Lawrence III JM, Moore TL, Madson KL, Rejent AJ, Osborn TG. Arthropathies of cystic fibrosis: case reports and review of the literature. J Rheumatol Suppl 1993;38:12-5.
77. Mc Guire S, Monaghan H, Tempany E. Arthritis in childhood cystic fibrosis. IrJ Med Sci 1982;151:253-4.
78. Phillips BM, David TJ. Pathogenesis and management of arthropathy in cystic fi-brosis. J R Soc Med 1986;79:44-50.
79. Schidlow DV, Goldsmith DP, Palmer J, Huang NN. Arthritis in cystic fibrosis. Arch Dis Child 1984;59:377-9.
80. Summers GD, Webley M. Episodic arthritis in cystic fibrosis: a case report. Br J Rheumatol 1986;25:393-5.
81. Tacetti G, Campana S, Marianelli L, Turchini S. Cystic fibrosis and episodic arthritis. J Pediatr 1995;126:848-9.
82. Vaze D. Episodic arthritis in cystic fibrosis. J Pediatr 1980;96:346.
83. Johnson S, Knox AJ. Arthropathy in cystic fibrosis. Respir Med 1994;88:567-70.
84. Pertuiset E, Menkes CJ, Lenoir G, Jehanne M, Douchain F, Guillot M. Les arthrites dans la mucoviscidose: 4 nouveaux cas et revue de la littérature. Rev Rhum Mal Osteoartic 1991;58:157-62.
85. Pertuiset E, Menkes CJ, Lenoir G, Jehanne M, Douchain F, Guillot M. Cystic fibrosis arthritis: a report of five cases. Br J Rheumatol 1992; 31:535-8.
86. Jones MM, Seilheimer DK, Pollack MS, Curry M, Crane MM, Rossen RD. Relationship of hypergammaglobulinemia, circulating immune complexes, and histocompatibility antigen profiles in patients with cystic fibrosis. Am Rev Respir Dis 1989;140:1636-9.
87. Turner MA, Baildam E, Patel L, David TJ. Joint disorders in cystic fibrosis. J R Soc Med 1997;90:13-20.
88. Bowler IM, Littlewood JM. Episodic arthritis in cystic fibrosis. Lancet 1992;340:244.
89. Wisnieski JJ, Todd EW, Fuller RK, et al. Immune complexes and complement abnormalities in patients with cystic fibrosis. Am Rev Respir Dis 1985;132:770-6.
90. Garty BZ, Scanlin T, Goldsmith DP, Grunstein M. Cutaneous manifestations of cystic fibrosis: possible role of cryoglobulins. Br J Dermatol 1989;121:655-8.
91. Hodson ME. Vasculitis and arthropathy in cystic fibrosis. J R Soc Med 1992;85(Suppl 19):38-40.
92. Fradin MS, Kalb RE, Grossman ME. Recurrent cutaneous vasculitis in cystic fibrosis. Pediatr Dermatol 1987;4:108-11.
93. Wulffraat NM, de Graeff-Meeder ER, Rijkers GT, Van der Laag H, Kuis W. Prevalence of circulating immune complexes in patients with cystic fibrosis arthritis. J Pediatr 1994;125:374-8.
94. Athreya BH, Born P, Rosenlund ML. Cystic fibrosis and hypertrophic osteoarthropa-thy in children. Report of three cases. Am J Dis Child 1975;129:634-7.
95. Crawford AM, Rabin HR, Fritzler MJ. Hypertrophic pulmonary osteoarthropathy in cystic fibrosis. Rheumatol Int 1985;5:283-4.
96. Matthay MA, Matthay RA, Mills DM, Lakshminarayan S, Cotton E. Hypertro-phic osteoarthropathy in adults with cystic fibrosis. Thorax 1976;31:572-5.
97. Lipnick RN, Glass RBJ. Bone changes associated with cystic fibrosis. Skeletal Radiol 1992;21:115-6.
98. Nathanson I, Riddleesberger MM. Pulmonary hypertrophic osteoarthropathy in cystic fibrosis. Pediatr Radiol 1980;135:649-51.
99. Gardiner PV, Roberts SD, Bell AL. Cystic fibrosis and rheumatoid arthritis. Br J Rheumatol 1989;28:179.
100. Sagransky DM, Greenwald RA, Gorvoy JD. Seropositive rheumatoid arthritis in a patient with cystic fibrosis. Am J Dis Child 1980;134: 319-20.
101. Pasteur MC, Helliwell SM, Houghton SJ, Webb SC, Foweraker JE, Coulden RA, et al. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med 2000;162:1277-84.
102. Puechal X. Bronchiectasis in rheumatoid arthritis. Rev Rhum Engl Ed 1998;65:447-50.
103. Solanki T, Neville E. Bronchiectasis and rheumatoid arthritis: is there an association? Br J Rheumatol 1994;33:139-41.
104. Benjamin CM, Clague RB. Psoriatic or cystic fibrosis arthropathy? Difficulty with diagnosis and management. Br J Rheum 1990;29: 301-2.
105. Cooper TJ, Day AJ, Weller PH, Geddes DM. Sarcoidosis in two patients with cystic fibrosis: a fortuitous association? Thorax 1987;42: 818-20.
106. Rettinger SD, Trulock EP, Mackay B, Auerbach HS. Sarcoidosis in an adult with cystic fibrosis. Thorax 1989;44:829-30.
107. Soden M, Tempany E, Brenishan B. Sarcoid arthropathy in cystic fibrosis. Br J Rheumatol 1989;28:341-3.
108. Bontempini L, Ghimenton C, Colombari R, Malena M, Luzzolino P, Canciani M, et al. Secondary amyloidosis and cystic fibrosis. A morphological and histochemical study of five cases. Histol Histopathol 1987;2:413-6.
109. McGlennen R, Burke BA, Dehner LP. Systemic amyloidosis complicating cystic fibrosis. Arch Pathol Lab Med 1986;110:879-84.
110. Ristow SC, Condemi JJ, Stuart D, Schwartz RH, Bryson MF. Systemic amyloidosis in cystic fibrosis. Am J Dis Child 1977;131:8868.
111. Skinner M, Pinnette A, Travis WD, Shwachman H, Cohen AS. Isolation and sequence analysis of amyloid protein AA from a patient with cystic fibrosis. J Lab Clin Med 1988;112:413-7.
112. Danisovicova A, Brezina M, Belan S, Kayserova H, Kaiserova E, Hruskovic I, et al. Magnetic resonance imaging in children receiving quinolones: no evidence of quinolone-induced arthropathy. Chemotherapy 1994;40:209-14.
113. Warren RW. Rheumatologic aspects of pediatric cystic fibrosis patients treated with fluoroquinolones. Pediatr Infect Dis J 1997;16: 118-22 [discussion 123-6].
114. Schaad UB, Stoupis C, Wedgwood J, Tschaeppeler H, Vock P. Clinical, radiologic and magnetic resonance monitoring for skeletal toxicity in pediatric patients with cystic fibrosis receiving a three-month course of ciprofloxacin. Pediatr Infect Dis J 1991;10:723-9.
115. Schaad UB, Sander E, Wedgwood J, Schaffner T. Morphologic studies for skeletal toxicity after prolonged ciprofloxacin therapy in two juvenile cystic fibrosis patients. Pediatr Infect Dis J 1992;11: 1047-9.
116. Hoiby N, Wiik A. Antibacterial precipitins and autoantibodies in serum of patients with cystic fibrosis. Scand J Respir Dis 1975;56:38-46.
117. Coffey M, Hassan J, Feighery C, Fitzgerald M, Bresnihan B. Rheumatoid factors in cystic fibrosis: association with disease manifestations and recurrent bacterial infections. Clin Exp Immunol 1989;77: 52-7.
118. Hassan J, Feighery C, Brenishan B, Whelan A. Prevalence of anti-Fab antibodies in patients with autoimmune and infectious diseases. Clin Exp Immunol 1992;89:423-6.
119. Finnegan MJ, Hinchcliffe J, Russel-Jones D, Neill S, Sheffield E, Jayne D, et al. Vasculitis complicating cystic fibrosis. Q J Med 1989; 267:609-21.
120. Moss RB, Hsu YP. Isolation and characterization of circulating immune complexes in cystic fibrosis. Clin Exp Immunol 1982;47: 301-8.
121. Bernischewsky M, Pollack M, Young LS, China D, Oscher AB, Barrett EV. Circulating immune complexes in cystic fibrosis. Pediat Res 1980;14:830-3.
122. Efthimiou J, Spickett G, Lane D, Thompson A. Antineutrophil cytoplasmic antibodies, cystic fibrosis, and infection. Lancet 1991;337: 1037-8.
123. Sediva A, Kolarova I, Bartunkova J. Antineutrophil cytoplasmic antibodies in children. Eur J Pediatr 1998;157:987-91.
124. Zhao MH, Jayne DRW, Ardiles LG, Culley F, Hodson ME, Lockwood CM. Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis. Q J Med 1996;89: 259-65.
125. Tacetti G, Campana S, Marianelli L, Procopio E, Turchini S. Autoantibodies against bactericidal/permeability increasing protein in cystic fibrosis patients: comment on the article by Hoffman and Specks. Arthritis Rheum 1999;42:1305-6.
126. Cooper T, Savige J, Nassis L, Paspaliaris B, Neeson P, Neil J, et al. Clinical associations and characterisation of antineutrophil cytoplasmic antibodies directed against bacteri-cidal/permeability-increasing protein and azurocidin. Rheumatol Int 2000;19:129-36.
127. De Graeff-Meeder ER, Rijkers GT, Voorhorst-Ogink MM, Kuis W, Van der Zee R, Van Eden W, et al. Antibodies to human HSP60 in patients with juvenile chronic arthritis, diabetes mellitus, and cystic fibrosis. Pediatr Res 1993;34:424-8.
128. Rose J, Gamble J, Schultz A, Lewinston N. Back pain and spinal deformity in cystic fibrosis. Am J Dis Child 1987;141:1313-6.
129. Haworth CS, Selby PL, Webb AK, Adams JE. Osteoporosis in adults with cystic fibrosis, J R Soc Med 1998;91(Suppl 34):14-8.
130. Lim JJ, Moss RB, Harkins EA, Marcus R, Bachrach LK. Bone mineral status in cystic fibrosis: risk factors for osteoporosis. Pediatr Pulmonol 1993(Suppl 9):278.
131. Laursen EM, Molgaard C, Michaelsen KF, Koch C, Muller J. Bone mineral status in 134 patients with cystic fibrosis. Arch Dis Child 1999;81:235-40.